Both THC and CBD, as well as methanandamide (an AEA analogue), have been shown to promote the expression of ICAM-1 on lung cancer cell lines, resulting in an increased susceptibility of tumor cells to lysis mediated by lymphokine-activated natural killer cells [53]. Here, ICAM1 is linked to lung carcinoma.